Treatment of Hypereosinophilic Syndromes with Prednisone, Hydroxyurea, and Interferon

Immunology and Allergy Clinics of North America

Volumn 27, Issue 3, 2007, Pages 493-518

  Butterfield, Joseph H ^a,b  

^a MAYO CLINIC   (United States)

^b Mayo Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; BETAMETHASONE; BUSULFAN; CLADRIBINE; CORTICOTROPIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DEFLAZACORT; DEXAMETHASONE; DIURETIC AGENT; ETOPOSIDE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HYDROXYUREA; IMATINIB; MELPHALAN; METHYLPREDNISOLONE; MOMETASONE FUROATE; PEGINTERFERON ALPHA; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PREDNISOLONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT INTERFERON; TROLEANDOMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE;

ACUTE HEART FAILURE; ACUTE MYOCYTE DEGENERATION; APOPTOSIS; AUTOIMMUNE DISEASE; AUTOIMMUNE THYROIDITIS; BED REST; BRAIN DISEASE; CARDIOVASCULAR DISEASE; CELL DEGENERATION; CELL SURVIVAL; CHILDHOOD DISEASE; CHROMOSOME ABERRATION; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; DEPRESSION; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG COST; DRUG INHIBITION; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE FUNCTION; HUMAN; HYPEREOSINOPHILIC SYNDROME; IN VITRO STUDY; LOW DRUG DOSE; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; NEPHROTOXICITY; NEUROLOGIC DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PRURITUS; PSORIASIS; REVIEW; SIDE EFFECT; SKIN DISEASE; SUICIDAL IDEATION; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TREATMENT RESPONSE; ULCERATIVE COLITIS; URTICARIA;

APOPTOSIS; HUMANS; HYDROXYUREA; HYPEREOSINOPHILIC SYNDROME; INTERFERON TYPE II; INTERFERON-ALPHA; PREDNISONE; RECEPTORS, GLUCOCORTICOID;

EID: 34548495600     PISSN: 08898561     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.iac.2007.06.003     Document Type: Review

References (212)

1. Germuth Jr. F.G., and Ottinger B. Effect of 12-hydroxy-11-dehydrocorticosterone (compound E) and of ACTH on arthus reaction and antibody formation in the rabbit. Proc Soc Exp Biol Med 4 (1950) 815-823
2. Dougherty T.F., and Schneebeli G.L. Role of cortisone in regulation of inflammation. Proc Soc Exp Biol Med 74 (1950) 854-859
3. Hench P.S., Kendall E.C., Slocumb C.H., et al. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotrophic hormone on rheumatoid arthritis; preliminary report. Proc Staff Meet Mayo Clin 24 (1949) 181-197
4. Shick R.M., Baggenstoss A.H., and Polley H.F. The effects of cortisone and ACTH on periarteritis nodosa and cranial arteritis. Preliminary report. Proc Staff Meet Mayo Clin 25 (1950) 135-144
5. Zappert J. Ueber das Vorkommen der eosinophilen Zellen in menschlichen blute. Z Klin Med 23 (1893) 227-308
6. Staubli C. Die klininische bedeutung der eosinophilie. Ergeb Inn Med Kinderheilkd 6 (1910) 192-220
7. Doe R.P., Flink E.B., and Goodsell M.G. Relationship of diurnal variation in 17-hydroxycorticosteroid levels in blood and urine to eosinophils and electrolyte excretion. J Clin Endocrinol Metab 16 (1956) 196-206
8. Visscher M.B., and Halberg F. Daily rhythms in the number of circulating eosinophils and some related phenomena. Ann N Y Acad Sci 59 (1955) 834-849
9. Arnoldsson H., and Helander E. Some aspects on the problem of eosinophilia. Errors of method, diurnal rhythm and eosinophilia in allergy. Acta Allergol 12 (1958) 96-112
10. Kaine H.D., Seltzer H.S., and Conn J.W. Mechanism of diurnal eosinophil rhythm in man. J Lab Clin Med 45 (1955) 247-252
11. Thorn G.W., Forsham P.H., Prunty F.T.G., et al. A test for adrenal cortical insufficiency. The response to pituitary adrenocorticotrophic hormone. J Am Med Assoc 137 (1948) 1005-1009
12. Prunty F.T.G. Techniques for the evaluation of adrenal cortical function by the use of adrenocorticotrophin: a review. J Clin Pathol 3 (1950) 87-105
13. Peterson A.P., Altman L.C., Hill J.S., et al. Glucocorticoid receptors in normal human eosinophils: comparison with neutrophils. J Allergy Clin Immunol 68 (1981) 212-217
14. Prin L., Lefebvre P.P., Gruart V., et al. Heterogeneity of human eosinophil glucocorticoid receptor expression in hypereosinophilic patients: absence of detectable receptor correlates with resistance to corticotherapy. Clin Exp Immunol 78 (1989) 383-389
15. Best W.R., and Samter M. Variation and error in eosinophil counts of blood and bone marrow. Blood 6 (1951) 61-74
16. Kellgren J.H., and Janus O. The eosinopenic response to cortisol and ACTH in normal subjects. Br Med J 2 (1951) 1183-1187
17. Essellier A.F., Jeanneret P., Kopp E., et al. Evidence against destruction of eosinophils by glucocorticoids as shown by in vitro experiments. Endocrinology 54 (1954) 477-479
18. Sevitt S. The spleen and blood eosinopenia. J Clin Pathol 8 (1955) 42-46
19. Essellier A.F., Jeanneret R.L., and Morandi L. The mechanism of glucocorticoid eosinopenia. Contribution to the physiology of eosinophile granulocytes. Blood 9 (1954) 531-549
20. Krippaehne M.L., and Osgood E.E. Studies of the influences of cortisone and hydrocortisone on human leukocytes in culture and in eosinophilic leukemia. Acta Haematol 13 (1955) 145-152
21. Suda T., Miura Y., Ijima H., et al. The effect of hydrocortisone on human granulopoiesis in vitro with cytochemical analysis of colonies. Exp Hematol 11 (1983) 114-121
22. Bjornson B.H., Harvey J.M., and Rose L. Differential effect of hydrocortisone on eosinophil and neutrophil proliferation. J Clin Invest 76 (1985) 924-929
23. Slovick F.T., Abboud C.N., Brennan J.K., et al. Modulation of in vitro eosinophil progenitors by hydrocortisone: role of accessory cells and interleukins. Blood 66 (1985) 1072-1079
24. Raghavachar A., Fleischer S., Frickhofen N., et al. T-lymphocyte control of human eosinophilic granulopoiesis: clonal analysis in an idiopathic hypereosinophilic syndrome. J Immunol 139 (1987) 3753-3758
25. Lamas A.M., Leon O.G., and Schleimer R.P. Glucocorticoids inhibit eosinophil responses to granulocyte-macrophage colony-stimulating factor. J Immunol 147 (1991) 254-259
26. Daffern P.J., Jagels M.A., Saad J.J., et al. Upper airway epithelial cells support eosinophil survival in vitro through production of GM-CSF and prostaglandin E2: regulation by glucocorticoids and TNF-alpha. Allergy Asthma Proc 20 (1999) 243-253
27. Schrezenmeier H., Thome S.D., Tewald F., et al. Interleukin-5 is the predominant eosinophilopoietin produced by cloned T lymphocytes in hypereosinophilic syndrome. Exp Hematol 21 (1993) 358-365
28. Yamaguchi Y., Hayashi Y., Sugama Y., et al. Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J Exp Med 167 (1988) 1737-1742
29. Wang J.M., Rambaldi A., Biondi A., et al. Recombinant human interleukin 5 is a selective eosinophil chemoattractant. Eur J Immunol 19 (1989) 701-705
30. Simon H.-U., Plotz S.G., Dummer R., et al. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 341 (1999) 1112-1120
31. Rolfe F.G., Hughes J.M., Armour C.L., et al. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 77 (1992) 494-499
32. Hallsworth M.P., Litchfield T.M., and Lee T.H. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. Immunology 75 (1992) 382-385
33. Wallen N., Kita H., Weiler D., et al. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 147 (1991) 3490-3495
34. Bloom J.W., Chacko J., Lohman I.C., et al. Differential control of eosinophil survival by glucocorticoids. Apoptosis 9 (2004) 97-104
35. Debierre-Grockiego F., Fuentes V., Prin L., et al. Differential effect of dexamethasone on cell death and STAT5 activation during in vitro eosinophilopoiesis. Br J Haematol 123 (2003) 933-941
36. Debierre-Grockiego F., Leduc I., Prin L., et al. Dexamethasone inhibits apoptosis of eosinophils isolated from hypereosinophilic patients. Immunobiology 204 (2001) 517-523
37. Letuve S., Druilhe A., Grandsaigne M., et al. Critical role of mitochondria, but not caspases during glucocorticosteroid-induced human eosinophil apoptosis. Am J Respir Cell Mol Biol 26 (2002) 565-571
38. Meagher L.C., Cousin J.M., Seckl J.R., et al. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156 (1996) 4422-4428
39. Zhang X., Moilanen E., Adcock I.M., et al. Divergent effect of mometasone on human eosinophil and neutrophil apoptosis. Life Sci 71 (2002) 1523-1534
40. Druilhe A., Letuve S., and Pretolani M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 8 (2003) 481-485
41. Dale D.C., Hubert R.T., and Fauci A. Eosinophil kinetics in the hypereosinophilic syndrome. J Lab Clin Med 87 (1976) 487-495
42. Hudson B., and Doig A. Observations on the nature of hormone-induced eosinopenia. Australas Ann Med 6 (1957) 228-237
43. Essellier A.F., and Wagner W.F. Das verhalten der eosinophilen in blut und knochenmark auf verbreichung von adrenocorticotrophin. Klin Wochenschr 30 (1952) 705-709
44. Root S.W., and Andrews G.A. Effect of ACTH on the eosinophil count in peripheral blood and bone marrow. Am J Med Sci 226 (1953) 304-309
45. Rosenthal R.L., Wald N., Yager A., et al. Effects of cortisone and ACTH therapy on eosinophils of the bone marrow and blood. Proc Soc Exp Biol Med 75 (1950) 740-741
46. Hench P.S., Kendall E.C., Slocumb C.H., et al. Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions. Arch Med Interna 85 (1950) 545-666
47. Rothstein I., Spring M., and Berley B.S. Effect of ACTH in a case of eosinophilic leukemia. N Y State J Med 53 (1953) 1461-1463
48. Engfeldt B., and Zetterstrom R. Disseminated eosinophilic collagen disease; a clinical and pathological study of a clinical entity related to Loffler's syndrome. Acta Med Scand 153 (1956) 337-353
49. Fadell E.J., Crone R.I., Leonard M.E., et al. Eosinophilic leukemia. Arch Intern Med 99 (1957) 819-823
50. Chen H.P., and Smith H.S. Eosinophilic leukemia. Ann Intern Med 52 (1960) 1343-1352
51. Bentley H.P., Reardon A.E., Knoedler J.P., et al. Eosinophilic leukemia. Report of a case, with review and classification. Am J Med 30 (1961) 310-322
52. Thomas J.R. Eosinophilic leukemia presenting with erythrocytosis. Blood 22 (1963) 639-645
53. Bruenwald H., Kiossoglou K.A., Mitus W.J., et al. Philadelphia chromosome in eosinophilic leukemia. Am J Med 39 (1965) 1003-1010
54. Brink A.J., and Weber H.W. Fibroplastic parietal endocarditis with eosinophilia. Loffler's endocarditis. Am J Med 34 (1963) 52-70
55. Roberts W.C., Liegler D.G., and Carbone P.P. Endomyocardial disease and eosinophilia. A clinical and pathologic spectrum. Am J Med 46 (1969) 28-42
56. Karle H., and Videbaek A. Eosinophilic leukaemia or a collagen disease with eosinophilia. Dan Med Bull 13 (1966) 41-45
57. Pierce L.E., Hosseinian A.H., and Constantine A.B. Disseminated eosinophilic collagen disease. Blood 29 (1967) 540-549
58. Hardy W.R., and Anderson R.E. The hypereosinophilic syndromes. Ann Intern Med 68 (1968) 1220-1229
59. Benvenisti D.A., and Ultman J.E. Eosinophilic leukemia: report of 5 cases and review of the literature. Ann Intern Med 71 (1969) 731-745
60. Fledelius H. Extreme persistent eosinophilia with high serum B12 values. A report of two cases. Acta Med Scand 187 3 (1970) 235-240
61. Sheperd A.J., Walsh C.H., Archer R.K., et al. Eosinophilia, splenomegaly and cardiac disease. Br J Haematol 2 (1971) 233-239
62. Manko M.A., Cooper J.H., and Myers R.N. Disseminated hypereosinophilic disease. Am J Gastroenterol 5 (1972) 318-325
63. Yam L.T., Li C.Y., Necheles T.F., et al. Pseudoeosinophilia, eosinophilic endocarditis and eosinophilic leukemia. Am J Med 53 (1972) 193-202
64. Flannery E.P., Dillon D.E., Freeman M.V., et al. Eosinophilic leukemia with fibrosing endocarditis and short Y chromosome. Ann Intern Med 77 (1972) 223-228
65. Chusid M.J., Dale D.C., West B.C., et al. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 54 (1975) 1-27
66. Parrillo J.E., Fauci A.S., and Wolff S.M. Therapy of the hypereosinophilic syndrome. Ann Intern Med 89 (1978) 167-172
67. Flaum M.A., Schooley R.T., Fauci A.S., et al. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations. Blood 58 (1981) 1012-1020
68. Parrillo J.E., Lawley T.J., Frank M.M., et al. Immunologic reactivity in the hypereosinophilic syndrome. J Allergy Clin Immunol 64 (1979) 113-121
69. Bush R.K., Geller M., Busse W.W., et al. Response to corticosteroids in the hypereosinophilic syndrome. Association with increased serum IgE levels. Arch Intern Med 138 (1978) 1244-1246
70. Edwards D., Wald J.A., Dobozin B.S., et al. Troleandomycin and methylprednisolone for treatment of the hypereosinophilic syndrome. [letter to the editor]. N Engl J Med 317 (1987) 573-574
71. Schooley R.T., Parrillo J.E., Wolff S.M., et al. Management of the idiopathic hypereosinophilic syndrome. In: Mahmoud A.A.F., and Austen K.F. (Eds). The eosinophil in health and disease (1980), Grune & Stratton, New York 323-343
72. Moore P.M., Harley J.B., and Fauci A.S. Neurologic dysfunction in the idiopathic hypereosinophilic syndrome. Ann Intern Med 102 (1985) 109-114
73. Kocaturk H., and Yilmaz M. Idiopathic hypereosinophilic syndrome associated with multiple intracardiac thrombi. Echocardiography 22 (2005) 675-676
74. Bell D., Mackay I.G., and Pentland B. Hypereosinophilic syndrome presenting as peripheral neuropathy. Postgrad Med J 61 (1985) 429-432
75. Prick J.J.W., Gabreels-Festen A.A.W.M., Korten J.J., et al. Neurological manifestations of the hypereosinophilic syndrome (HES). Clin Neurol Neurosurg 90 (1988) 269-273
76. Moreau T., Derex L., and Confavreux C. Acute encephalopathy and idiopathic hypereosinophilic syndrome: clinical and MRI response to early steroid treatment. Eur J Neurol 4 (1997) 618-621
77. Fernandez-Miranda C., Ruiz L., Dominguez J., et al. Reversible encephalopathy as first manifestation of hypereosinophilic syndrome. Eur J Intern Med 7 (1996) 41-42
78. Lebbink J., and Laterre E.C. Idiopathic hypereosinophilic syndrome revealed by central nervous system dysfunction. Acta Neurol Belg 96 (1996) 137-140
79. Borer J.S., Henry W.L., and Epstein S.E. Echocardiographic observations in patients with systemic infiltrative disease involving the heart. Am J Cardiol 39 (1977) 184-188
80. Londhey V.A., Nadkar M.Y., Kini S.H., et al. Idiopathic hypereosinophilic syndrome manifesting as pulmonary oedema. J Assoc Physicians India 51 (2003) 414-415
81. Parrillo J.E., Borer J.S., Henry W.L., et al. The cardiovascular manifestations of the hypereosinophilic syndrome. Prospective study of 26 patients, with review of the literature. Am J Med 67 (1979) 572-582
82. Davies J., Spry C.J.F., Sapsford R., et al. Cardiovascular features of 11 patients with eosinophilic endomyocardial disease. Quarterly Journal of Medicine, New Series LII 205 (1983) 23-29
83. Pardanani A., Reeder T., Porrata L.F., et al. Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders. Blood 101 (2003) 3391-3397
84. Pitini V., Arrigo C., Azzarello D., et al. Serum concentration of cardiac troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcomes. [letter to the editor]. Blood 102 (2003) 3456-3457
85. Harley J.B., Fauci A.S., and Gralnick H.R. Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. Am J Cardiol 32 (1983) 321-324
86. Huntgeburth M., Lindner M., Fries J.W.U., et al. Hypereosinophilic syndrome associated with acute necrotizing myocarditis and cardiomyopathy. Z Kardiol 94 (2005) 761-766
87. Hayashi S.-I., Isobe M., Okubo Y., et al. Improvement of eosinophilic heart disease after steroid therapy: successful demonstration by endomyocardial biopsied specimens. Heart Vessels 14 (1999) 104-108
88. Maruyoshi H., Nakatani S., Yasumura Y., et al. Loffler's endocarditis associated with unusual ECG change mimicking posterior myocardial infarction. Heart Vessels 18 (2003) 43-46
89. Arsiwala S., Peek G., Davies M., et al. Hypereosinophilic syndrome: cause of prosthetic valve obstruction. J Thorac Cardiovasc Surg 110 (1995) 545-546
90. Frustaci A., Abdulla A.K., Possati G., et al. Persisting hypereosinophilia and myocardial activity in the fibrotic stage of endomyocardial disease. Chest 96 (1989) 674-675
91. Ponsky T.A., Brody F., Giordano J., et al. Brachial artery occlusion secondary to hypereosinophilic syndrome. J Vasc Surg 42 (2005) 796-799
92. Ohashi H., Itoh M., Goto Y., et al. Pulmonary thromboembolism in a patient with idiopathic hypereosinophilic syndrome. Japanese Journal of Rheumatology 7 (1997) 115-121
93. Yeung T., Lau S., and Wong K. An unusual case of hypereosinophilic syndrome and disseminated intravascular coagulation. Chin Med J 118 (2005) 1582-1584
94. Lee J.S., Lee H.-K., Lee S.S., et al. A case of idiopathic hypereosinophilic syndrome complicated with pulmonary thromboembolism and disseminated intravascular coagulation. Tuberculosis and Respiratory Diseases 57 (2004) 573-578
95. Kazmierowski J.A., Chusid M.J., Parrillo J.E., et al. Dermatologic manifestations of the hypereosinophilic syndrome. Arch Dermatol 114 (1978) 531-535
96. Barna M., Kemeny L., and Dobozy A. Skin lesions as the only manifestation of the hypereosinophilic syndrome. Br J Dermatol 136 (1997) 646-647
97. Leiferman K.M., O'Duffy J.D., Perry H.O., et al. Recurrent incapacitating mucosal ulcerations. A prodrome of the hypereosinophilia syndrome. JAMA 247 (1982) 1018-1020
98. Aksahoshi M., Hoshino S., Teramura M., et al. Recurrent oral and genital ulcers as the prodrome of the hypereosinophilic syndrome: report of a probable case. Nippon Naika Gakkai Zasshi 76 (1987) 421-424
99. Barouky R., Bencharif L., Badet F., et al. Mucosal ulcerations revealing primitive hypereosinophilic syndrome. Eur J Dermatol 13 (2003) 207-208
100. Tsunemi Y., Idezuki T., Nakamura K., et al. Dermal endothelial cells express eotaxin in hypereosinophilic syndrome. J Am Acad Dermatol 49 (2003) 918-921
101. Offidani A., Bernardini M.I., Simonetti O., et al. Hypereosinophlic dermatosis: skin lesions as the only manifestation of the idiopathic hypereosinophilic syndrome?. Br J Dermatol 143 (2000) 675-677
102. Aragone M.G., Nigro A., Parodi A., et al. Solar urticaria as the presenting sign of hypereosinophilic syndrome. Int J Dermatol 38 (1999) 234
103. Delevaux I., Andrie M., Chipponi J., et al. A rare manifestation of idiopathic hypereosinophilic syndrome: sclerosing cholangitis. Dig Dis Sci 47 (2002) 148-151
104. Scheurlen M., Mork H., and Weber P. Hypereosinophilic syndrome resembling chronic inflammatory bowel disease with primary sclerosing cholangitis. J Clin Gastroenterol 14 (1992) 59-63
105. Amin M.A., Hamid M.A., and Saba S. Hypereosinophilic syndrome presenting with eosinophilic colitis, enteritis and cystitis. Chin J Dig Dis 6 (2005) 206-208
106. Ichikawa N., Taniguchi A., Akama H., et al. Sclerosing cholangitis associated with hypereosinophilic syndrome. Intern Med 36 (1997) 561-564
107. Valente A.I., Pinto H.C., Ramalho F., et al. Idiopathic hypereosinophilic syndrome presenting as cholestatic liver disease. Eur J Gastroenterol Hepatol 9 (1997) 815-817
108. Reyes M., Abraham C., Abedi M., et al. Hypereosinophilic syndrome with hepatobiliary masses and obstructive jaundice. Ann Allergy Asthma Immunol 94 (2005) 25-28
109. Yarbro J.W. Mechanism of action of hydroxyurea. Semin Oncol 19 (1992) 1-10
110. Dresch C., Faille A., Poirer O., et al. Hydroxyurea suicide study of the kinetic heterogeneity of colony forming cells in human bone marrow. Exp Hematol 7 (1979) 337-344
111. Malbrain M.L.N.G., Vanden Bergh H., and Zachee P. Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete haematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality. Br J Haematol 92 (1996) 176-183
112. Chusid M.J., and Dale D.C. Eosinophilic leukemia. Remission with vincristine and hydroxyurea. Am J Med 59 (1975) 297-300
113. Solley G.O., Maldonado J.E., Gleich G.J., et al. Endomyocardiopathy with eosinophilia. Mayo Clin Proc 51 (1976) 697-708
114. Lombardi C., Rusconi C., Faggiano P., et al. Successful reduction of endomyocardial fibrosis in a patient with idiopathic hypereosinophilic syndrome: a case report. Angiology 46 (1995) 345-351
115. Diaz F., and Collazos J. Reversible cerebellar involvement in the idiopathic hypereosinophilic syndrome. Postgrad Med J 75 (1999) 477-479
116. Coutant G., Bletry O., Prin L., et al. Traitement des syndromes hypereosinophiliques a expression myeloproliferative par l'association hydroxyurea-interferon alpha. Annales de Medicine Interne 144 (1993) 243-250
117. Bletry O., and Papo T. Les interferons. Interferons alpha et gamma: indications dans es maladies systemiques. Annales de Medicine Interne 144 (1993) 557-562
118. Sato H., Danbara M., Tamura M., et al. Eosinophilic leukaemia with a t(2;5) (p23;q35) translocation. Br J Haematol 87 (1994) 404-406
119. Demiroglu H., and Dundar S. Combination of interferon-alpha and hydroxyurea in the treatment of idiopathic hypereosinophilic syndrome. Br J Haematol 97 (1997) 927-940
120. Means-Markwell M., Burgess T., de Keratry D., et al. Eosinophilia with aberrant T cells and elevated serum levels of interleukin-2 and interleukin-15. N Engl J Med 342 (2000) 1568-1571
121. Butterfield J.H., and Sharkey S.W. Control of hypereosinophilic syndrome-associated recalcitrant coronary artery spasm by combined treatment with prednisone, imatinib mesylate and hydroxyurea. Experimental and Clinical Cardiology 11 (2006) 25-28
122. Murphy P.T., Fenelly D.F., Stuart M., et al. Alfa-interferon in a case of hypereosinophilic syndrome. Br J Haematol 75 (1990) 619-620
123. Zielinski R.M., and Lawrence W.D. Interferon-α for the hypereosinophilic syndrome. Ann Intern Med 113 (1990) 716-718
124. Fruehauf S., Fiehn C., Haas R., et al. Sustained remission of idiopathic hypereosinophilic syndrome following α-Interferon therapy. Acta Haematol 89 (1993) 91-93
125. Yamada O., Kitahara K., Imamura K., et al. Clinical and cytogenetic remission induced by interferon-α in a patient with chronic eosinophilic leukemia associated with a unique t(3;9;5) translocation. Am J Hematol 58 (1998) 137-141
126. Ceretelli S., Capochiani E., and Petrini M. Interferon-α in the idiopathic hypereosinophilic syndrome: consideration of five cases. Ann Hematol 77 (1998) 161-164
127. Yoon T.Y., Ahn G.-B., and Chang S.-H. Complete remission of hypereosinophilic syndrome after interferon-α therapy: report of a case and literature review. J Dermatol 27 (2000) 110-115
128. Kobayashi M., Katayama T., Ochiai S., et al. Interferon-a therapy for the myeloproliferative variants of hypereosinophilic syndrome. Japan Journal of Clinical Hematology 34 (1993) 367-372
129. Bockenstedt P.L., Santinga J.T., and Bolling S.F. α-Interferon treatment for idiopathic hypereosinophilic syndrome. Am J Hematol 45 (1994) 248-251
130. Acaba L., Mangual A., and Garcia E.V. Excellent response to interferon therapy in a patient with hypereosinophilic syndrome and elevated serum immunoglobulin E levels. Bol Asoc Med P R 92 (2000) 59-62
131. Baratta L., Afeltra A., Delfino M., et al. Favorable response to high-dose interferon-alpha in idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy. Case report and literature review. Angiology 53 (2002) 465-470
132. Schoffski P., Ganser A., Pascheberg U., et al. Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(3;7) aberration. Ann Hematol 79 (2000) 95-98
133. Hansen P.B., Johnsen H.E., and Hippe E. Hypereosinophilic syndrome treated with α-interferon and granulocyte colony-stimulating factor but complicated by nephrotoxicity. Am J Hematol 43 (1993) 66-68
134. Butterfield J.H., and Gleich G.J. Interferon-α treatment of six patients with the idiopathic hypereosinophilic syndrome. Ann Intern Med 121 (1994) 648-653
135. Busch F.W., Schmidt H., and Steinke B. Alpha-Interferon for the hypereosinophilic syndrome. Ann Intern Med 114 (1991) 338-339
136. Esteve K., Cervamtes F., Bosch F., et al. Tratamiento con interferon alfa del sindrome hipereosinofilico idiopatico resistente a la terapeutica convencional. Medicina Cliniica 106 (1996) 30-32
137. Aldebert D., Lamkhioued B., Desaint C., et al. Eosinophils express a functional receptor for interferon α: inhibitory role of interferon α on the release of mediators. Blood 87 (1996) 2354-2360
138. Durack D.T., Ackerman S.J., Loegering D.A., et al. Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci U S A 78 (1981) 5165-5169
139. Kishimoto C., Spry C.J., Tai P.C., et al. The in vivo cardiotoxic effect of eosinophilic cationic protein in an animal preparation. Jpn Circ J 50 (1986) 1264-1267
140. Broxmeyer H.E., Lu L., Platzer E., et al. Comparative analysis of the influences of human gamma, alpha and beta interferons on human multipotential (CFU-GEMM), erythroid (BFU-E) and granulocyte-macrophage (CFU-GM) progenitor cells. J Immunol 131 (1983) 1300-1305
141. Kioke T., Nakamura Y., and Enokihara H. Interferon-α inhibits interleukin-5 and granulocyte-macrophage colony stimulating factor production by lymphocytes and suppresses eosinophil colony formation from bone marrow progenitor cells. Dokkyo Journal of Medical Sciences 25 (1998) 45-52
142. Desreumaux P., Janin A., Dubucquoi S., et al. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 82 (1993) 1553-1560
143. Paul W.E., and Seder R.A. Lymphocyte responses and cytokines. Cell 76 (1994) 241-251
144. Gutterman J.U. Cytokine therapeutics: lessons from interferon α. Proc Natl Acad Sci U S A 91 (1994) 1198-1205
145. Parronchi P., De Carli M., Manetti R., et al. IL-4 and IFN (α and γ) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T cell clones. J Immunol 149 (1992) 2977-2983
146. + T cells. [letter to the editor]. Blood 89 (1997) 1110-1111
147. Ochiai K., Iwamoto I., Takahashi H., et al. Effect of IL-4 and interferon-gamma (IFN-gamma) on IL-3 and IL-5-induced eosinophil differentiation from human cord blood mononuclear cells. Clin Exp Immunol 99 (1995) 124-128
148. Morita M., Lamkhioued B., Gounni A.S., et al. Induction by interferons of human eosinophil apoptosis and regulation by interleukin-3, granulocyte/macrophage-colony stimulating factor and interleukin-5. Eur Cytokine Netw 7 (1996) 725-732
149. Nakajuma T., Yamashita N., Matsui H., et al. Induction of differentiation into monocyte/macrophage cell lineage of a human eosinophilic leukaemia cell line EoL-1 by simultaneous stimulation with tumor necrosis factor-α and interferon-γ. Br J Haematol 89 (1995) 258-265
150. Krishnaswamy G., Smith J.K., Srikanth S., et al. Lymphoblastoid interferon-α inhibits T cell proliferation and expression of eosinophil-activating cytokines. J Interferon Cytokine Res 16 (1996) 819-827
151. Bochner B.S., Klunk D.A., Sterbinsky S.A., et al. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol 154 (1995) 799-803
152. Resnick M.B., and Weller P.F. Mechanisms of eosinophil recruitment. Am J Respir Cell Mol Biol 8 (1993) 349-355
153. Enokihara H., Nakamura Y., Nagashima S., et al. Regulation of interleukin-5 production by interleukin-4, interferon-alpha, transforming growth factor β and interleukin-6. Int Arch Allergy Immunol 104 (1994) 44-45
154. Krishnaswamy G., Hall K., Youngberg G., et al. Regulation of eosinophil-active cytokine production from human cord blood-derived mast cells. J Interferon Cytokine Res 22 (2002) 379-388
155. Kitano K., Ichikawa N., Mahbub B., et al. Eosinophilia associated with proliferation of CD(3+)4-(8-) alpha beta+ T cells with chromosome 16 anomalies. Br J Haematol 92 (1996) 315-317
156. - T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 183 (1996) 1071-1082
157. Cogan E., Schandene L., Crusiaux A., et al. Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 330 (1994) 535-538
158. Schandene L., Roufosse F., de Lavarfeille A., et al. Interferon α prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood 96 (2000) 4285-4292
159. Prin L., Plumas J., Gruart V., et al. Elevated serum levels of soluble interleukin-2 receptor: a marker of disease activity in the hypereosinophilic syndrome. Blood 78 (1991) 2626-2632
160. Kitano K., Ichikawa N., Shimodaira S., et al. Eosinophilia associated with clonal T-cell proliferation. Leuk Lymphoma 27 (1997) 335-342
161. Keidan A.J., Castovsky C., De Castro J.T., et al. Hypereosinophilic syndrome preceding T cell lymphoblastic lymphoma. Clin Lab Haematol 7 (1985) 83-88
162. Kim C.J., Park S.H., and Chi J.G. Idiopathic hypereosinophilic syndrome terminating as disseminated T-cell lymphoma. Cancer 67 (1991) 1064-1069
163. Klion A.D., Bochner B.S., Gleich G.J., et al. Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report. J Allergy Clin Immunol 117 (2006) 1292-1302
164. + lymphocytosis of Th2/Th0 type. Int J Hematol 75 (2002) 281-284
165. Quiquandon I., Claisse J.F., Capiod J.C., et al. α-Interferon and hypereosinophilic syndrome with trisomy 8: karyotypic remission. Blood 85 (1995) 2284-2285
166. van Leuween B.H., Martinson M.E., Webb G.C., et al. Molecular organization of the cytokine gene cluster involving the human IL-3, IL-4, IL-5, and GM-CSF genes, on human chromosome 5. Blood 73 (1989) 1142-1148
167. Luciano L., Catalano L., Sarrantonio C., et al. αIFN-induced hematologic and cytogenetic remission in chronic eosinophilic leukemia with t(1;5). Haematologica 84 (1999) 651-653
168. Watanabe K., Tournilhad O., and Camilleri L.F. Recurrent thrombosis of prosthetic mitral valve in idiopathic hypereosinophilic syndrome. J Heart Valve Dis 11 3 (2002) 447-449
169. Granjo E., Lima M., Lopes J.M., et al. Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. Acta Haematologica 107 (2002) 108-112
170. van den Anker-Lugtenburg P.J., and van't Veer M.B. Alpha-interferon in a case of hypereosinophilic syndrome. Br J Haematol 77 (1991) 258
171. Canonica G.W., Passalacqua G., Pronzato C., et al. Effective long-term α-interferon treatment for hypereosinophilic syndrome. J Allergy Clin Immunol 96 (1995) 131-155
172. DeYampert N.M., and Beck L.A. Eosinophilia and multiple erythematous indurated plaques. Arch Dermatol 133 (1997) 1579-1584
173. Milewski M., Libura M., Undas A., et al. Interferon gamma abolishes aspirin-induced bronchoconstriction in a hypereosinophilic non-atopic patient. [abstract 2125]. Eur Respir J 8 Suppl 19 (1995) 432S
174. Vilcek J., and Feldman M. The sequences of IFN-alfa-2a and IFN-alfa-2b differ by one amino acid. Historical review: cytokines as therapeutics and targets of therapeutics. Trends Pharmacol Sci 25 4 (2004) 201-209
175. Dicato M., Ries F., and Duhem C. Long lasting remission of hypereosinophilic syndrome (HES) after alpha-interferon (IFN) treatment. Blood 84 10 Suppl 1 (1994) 631A
176. Grace M., Youngster S., Gitlin G., et al. Structural and biologic characterization of pegylated recombinant IFN-α2b. J Interferon Cytokine Res 21 (2001) 1103-1115
177. Butterfield J.H. PEG-Interferon after Interferon alfa-2b for hypereosinophilic syndrome. J Allergy Clin Immunol 119 (2007) S222
178. Gisslinger H., Eichinger S., Gilly B., et al. Exacerbation of autoimmunity during therapy with recombinant interferon alpha for hematological disorders. Ann Hematol 65 Suppl (1992) A8
179. Raison C.L., Demetrashivili M., Capuron L., et al. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 19 (2005) 105-123
180. Hendrick A. Case report psychosis during interferon in eosinophilic leukaemia. Clin lab Haematol 16 (1994) 295-296
181. Kook H., Cho D., Noh H.-Y., et al. Chronic eosinophilic leukemia with unique chromosomal abnormality, add(8)(p23), in a 14-month girl: treatment with imatinib mesilate. [abstract 4931]. Blood 100 11 (2002) 344-345
182. Nassar G.M., Pedro P., Remmers R.E., et al. Reversible renal failure in a patient with the hypereosinophilic syndrome during therapy with alpha interferon. Am J Kidney Dis 31 (1998) 121-126
183. Kanthawatana S., Irani A.M., and Schwartz L.B. Recombinant Interferon-alpha (IFNα) and pregnancy in a patient with hypereosinophilic syndrome. J Allergy Clin Immunol 101 1 (1998) S20-S2S
184. Blanquer A., Lopez A., Tarin F., et al. Alpha interferon for hypereosinophilic syndrome. Am J Hematol 47 4 (1994) 332-333
185. George B.O., Abdelaal M.A., Gang M.T., et al. Idiopathic hypereosinophilic syndrome: a report of four cases in Arabs, and a review of the literature. Afr J Med Sci 30 (2001) 241-249
186. Papo T., Piette J.-C., and Hermine O. Treatment of the hypereosinophilic syndrome with interferon-α. Ann Intern Med 123 (1995) 155-156
187. Chockalingam A., Jalil A., Shadduck R.K., et al. Case Report. Allogeneic peripheral blood stem cell transplantation for hypereosinophilic syndrome with severe cardiac dysfunction. Bone Marrow Transplant 23 (1999) 1093-1094
188. Xicoy B., Batlle M., Grau J., et al. Transient demyelinating neurologic lesions in a patient with idiopathic hypereosinophilic syndrome. [letter to the editor]. Am J Hematol 69 (2002) 153-154
189. Katz H.T., Haque S.J., and Hsieh F.H. Pediatric hypereosinophilic syndrome (HES) differs from adult HES. J Pediatr 146 (2005) 134-136
190. Tan A.M., Downie P.J., and Ekert H. Hypereosinophilia syndrome with pneumonia in acute lymphoblastic leukemia. Aust Paediatr J 23 (1987) 359-361
191. Blatt J., Pjoujansky R., Horn M., et al. Idiopathic hypereosinophilic syndrome terminating in acute lymphoblastic leukemia. Pediatr Hematol Oncol 9 (1992) 151-155
192. Narayanan G., Hussain B.M., Chandralekha B., et al. Hypereosinophilic syndrome in acute lymphoblastic leukemia: case report and literature review. Acta Oncol 39 (2000) 241-243
193. Hill A., and Metry D. Urticarial lesions in a child with acute lymphoblastic leukemia and eosinophilia. Pediatr Dermatol 20 (2003) 502-505
194. Takamizawa M., Iwata T., Watanabe K., et al. Elevated production of interleukin-4 and interleukin-5 by T cells in a child with idiopathic hypereosinophilic syndrome. J Allergy Clin Immunol 93 (1994) 1076-1078
195. Alfaham M.A., Ferguson S.D., Sihra B., et al. The idiopathic hypereosinophilic syndrome. Arch Dis Child 62 (1987) 601-613
196. Ito T., Harada K., and Takada G. An infant with hypereosinophilic syndrome and heart failure markedly responded to prednisolone: serial changes of left ventricular wall thickening and left ventricular diastolic dysfunction observed by echocardiography. Heart Vessels 13 (1998) 302-305
197. Kao C.C., Ou L.S., Lin S.J., et al. Childhood idiopathic hypereosinophilic syndrome: report of a case. Asian Pac J Allergy Immunol 20 2 (2002) 121-126
198. Funahashi S., Masaki I., and Furuyama T. Hypereosinophilic syndrome accompanying gangrene of the toes with peripheral arterial occlusion: A case report. Angiology 57 (2006) 231-234
199. Subhash H.S., George P., Sowmya G., et al. Progressive dilated cardiomyopathy in a patient with hypereosinophilic syndrome despite prednisone induced hematological remission. J Assoc Physicians India 49 (2001) 944-945
200. Marshall G.M., and White L. Effective therapy for a severe case of the idiopathic hypereosinophilic syndrome. Am J Pediatr Hematol Oncol 11 (1989) 178-183
201. Horenstein M.S., Humes R., Epstein M.L., et al. Loffler's endocarditis presenting in 2 children as fever with eosinophilia. Pediatrics 110 (2002) 1014-1018
202. Rives S., Alcorta I., Toll T., et al. Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement. J Pediatr Hematol Oncol 27 (2005) 663-665
203. Rizzari C., Cantu-Rajnoldi A., and Masera G. Efficacy of prolonged low-dose steroid treatment in a child with idiopathic hypereosinophilic syndrome: a case report. Pediatr Hematol Oncol 12 (1995) 209-212
204. Venkatesh C., Mahender E., Janani S., et al. Hypereosinophilic syndrome. Indian J Pediatr 73 (2006) 237-239
205. Bakhshi S., Hamre M., Mohamed A.N., et al. t(5;9)(q11;134): a novel familial translocation involving abelson oncogene and association with hypereosinophilia. J Pediatr Hematol Oncol 25 (2003) 82-84
206. Uckan D., Hicsonmez G., Tunc B., et al. The analysis of eosinophil and lymphocyte phenotype following single dose of high-dose methylprednisolone in two siblings with marked hyypereosinohilia. Clin Lab Haematol 23 (2001) 33-37
207. Roy R., Ladusans E., and Keenen R. Acute hypereosinophilia associated with right ventricular thrombosis. Eur J Pediatr 164 (2005) 448-450
208. Hii M.W., Firkin F.C., MacIsaac A.I., et al. Obstructive prosthetic mitral valve thrombosis in idiopathic hypereosinophilic syndrome: a case report and review of the literature. J Heart Valve Dis 15 (2006) 721-725
209. Spiegel R., Miron D., Fink D., et al. Eosinophilic pericarditis: a rare complication of idiopathic hypereosinophilic syndrome in a child. Pediatr Cardiol 25 (2004) 690-692
210. Jain A.K., Dubey A.P., and Sudha S. Idiopathic hypereosinophilic syndrome-unusual presentation. Indian Pediatr 41 (2004) 79-82
211. Pellier I., Le Moine P., Rialland X., et al. Myelodysplastic syndrome with t(5;12)(q31; p12-p13) and eosinophilia: a pediatric case with review of literature. J Pediatr Hemat Oncol 18 (1996) 285-288
212. Leblond P., Lepers S., Thebaud E., et al. Idiopathic hypereosinophilic syndrome: a case report in an infant. Arch Pediatr 11 (2004) 219-222